Covid-19 and GI Cancer Management


The safety of upper gastrointestinal cancer patients in the SARS-CoV-2 outbreak is extremely important and most surgeons need to establish a contingency management.The COVID-19 outbreak makes surgical procedures extremely difficult to be performed. The most common criteria to prioritize patients for surgical treatment are stage, tumor biology, presence of tumor-related symptoms, the risk of tumor to become non-resectable, and time interval from neoadjuvant therapy. The multidisciplinary teams can help assigning a priority level to each clinical case.


    Related Conference of Covid-19 and GI Cancer Management

    July 25-26, 2024

    3rd International Conference on Gastroenterology and Liver

    Amsterdam, Netherlands
    November 21-22, 2024

    23rd World Congress on Gastrointestinal Cancer

    Dubai, UAE

    Covid-19 and GI Cancer Management Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in